Phase II trial of high-dose topotecan, melphalan and CY with autologous stem cell support for multiple myeloma

S. M A Kazmi, R. M. Saliba, M. Donato, M. Wang, C. Hosing, S. Qureshi, P. Anderlini, U. Popat, R. E. Champlin, S. A. Giralt, M. H. Qazilbash

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of high-dose topotecan, melphalan and CY with autologous stem cell support for multiple myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences